LRMR,Larimar Therapeutics, Inc. | Healthcare

Healthcare

LRMR

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Larimar Therapeutics, Inc.LRMR

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Its lead product candidate is CTI-1601, which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease.

The company is headquartered in Bala Cynwyd, Pennsylvania.

Latest News >

LoanDepot, Smith Douglas Homes Form Joint Venture to Support Financing for New Home Buyers

Nov 4, 2024

10:56 AM EST, 11/04/2024 (MT Newswires) -- LoanDepot ( LDI ) and Smith Douglas Homes ( SDHC ) said Monday they established a joint venture called Ridgeland Mortgage to support financing for new home buyers. The joint venture will operate in Atlanta, Georgia; Houston, Texas; Birmingham and Huntsville, Alabama; Charlotte and Raleigh, North Carolina; and Chattanooga and Nashville, Tennessee, the...

Advance Auto Parts Completes Sale of Worldpac to Carlyle

Nov 4, 2024

10:59 AM EST, 11/04/2024 (MT Newswires) -- Advance Auto Parts ( AAP ) said Monday it has completed the previously announced $1.5 billion sale of Worldpac, its automotive parts wholesale distribution business, to Carlyle Group ( CG ) . Net proceeds from the sale are expected to be roughly $1.2 billion, the company added. Shares of Advance Auto Parts (...

Myriad Genetics Disputes Inclusion of GeneSight in UnitedHealthcare's Coverage Restriction

Nov 4, 2024

10:56 AM EST, 11/04/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said Monday that it strongly disagrees with UnitedHealthcare's decision to restrict coverage access to multi-gene panel pharmacogenetic tests, including Myriad's GeneSight test, under the commercial and individual exchange benefit plans. The updated policy, which takes effect on Jan. 1, is based on the rationale that there is insufficient...

Eni Completes $1 Billion Alaska Asset Sale, Fast-Tracks Portfolio Goal: Details

Nov 4, 2024

Eni S.p.A. shares are trading higher on Monday. The company disclosed the successful completion of the sale of 100% of its Nikaitchuq and Oooguruk assets in Alaska to Hilcorp for a total value of $1 billion. The transaction, approved by all relevant authorities, aligns with Eni’s strategy to streamline its upstream portfolio by divesting non-core assets. This sale contributes to Eni’s...